![]() |
市場調査レポート
商品コード
1439396
手術用エネルギー器具/電気手術用デバイス - 世界市場の考察、競合情勢、市場予測(2030年)Surgical Energy Instruments/Electrosurgical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
手術用エネルギー器具/電気手術用デバイス - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の手術用エネルギー器具/電気手術用デバイスの市場規模は、2023年に85億2,099万米ドル、2030年までに124億180万米ドルに達し、2024年~2030年の予測期間にCAGRで6.64%の成長が見込まれます。手術用エネルギー器具/電気手術用デバイスの需要は、心血管疾患、神経疾患、婦人科疾患などの慢性疾患の有病率の増加、外科手術の件数の増加、老人患者の負担の増大、製品開発と設計改良における技術の進歩により、成長を示しています。
手術用エネルギー器具/電気手術用デバイスの市場力学
手術用エネルギー器具/電気手術用デバイス市場は、遺伝、加齢、肥満、不健康なライフスタイルなどのさまざまな要因による心不全や脳卒中などのさまざまな慢性疾患の有病率の上昇により、市場収益の増加を示しています。世界保健機関(WHO)(2023)によると、2019年、心血管疾患(CVD)は世界的に主な死因の1つでした。2019年にCVDで死亡した人は約1,790万人と推定され、全世界の死亡者数の32%を占めています。ほとんどの心血管疾患は何らかの手術によって治療されます。
さらに、加齢はほとんどの慢性疾患の危険因子の1つであるため、高齢患者の負担の増大は慢性疾患の有病率を増加させる可能性があります。例えば、WHO(2022)によると、2030年までに世界の6人に1人が60歳以上の高齢者となります。2050年までに、世界の60歳以上の人口は倍増します。したがって、世界の高齢患者の増加により、予測期間に電気手術用デバイスの需要が増加する可能性があります。
手術用エネルギー器具/電気手術用デバイス市場の成長をもたらすもう1つの主な要因は、世界全体での手術件数の増加です。例えば、Lifespan Health System organization(2023)によると、米国では毎年約500万件の開心術が行われています。また、Plastic Surgery and Statistics Report(2023)によると、2020年に米国で約1,560万件の美容整形手術が行われました。さらにこの資料は、2020年に米国で実施された低侵襲美容手術は約1,320万件であったと述べています。
したがって、開心術や美容手術などの手術件数の増加とともに、さまざまな慢性疾患の有病率の上昇が、手術用エネルギー器具の需要拡大に寄与すると予測され、ひいては手術用エネルギー器具/電気手術用デバイスの需要拡大につながり、予測期間に世界の手術用エネルギー器具/電気手術用デバイス市場を前進させることが見込まれます。
しかし、手術用エネルギー器具の承認に関連する厳しい規制ガイドラインや、医療市場における熟練労働力の不足も、手術用エネルギー器具/電気手術用デバイス市場の成長を抑制します。
前述の要因に加え、COVID-19を封じ込め、ウイルス感染の拡大を食い止めるために必要な措置としてロックダウン規制が課されたため、手術用エネルギー器具/電気手術用デバイス市場は一時的に後退した時期がありました。COVID-19パンデミックは、世界各国とその医療システムに深刻な影響を及ぼし、COVID-19に感染した患者だけでなく、その他の患者にも大きな影響を与えました。この状況により、リソースを管理し確保するためにいくつかの手術がキャンセルされ、いくつかの病院はこれらの手術を支援する役割を担う専門家の不足に直面していました。例えば、British Journal of Surgery Report(2023)によると、2020年5月、インドでは1週間あたり約4万8,728件の手術がキャンセルされ、12週間で約58万5,000件の手術が行われたと推定されています。しかし、ワクチンの導入やさらなる流行に対する戦略的計画に対する各国政府の注目の高まりにより、手術用エネルギー器具/電気手術用デバイスの需要は伸びると予測され、それにより予測期間の手術用エネルギー器具/電気手術用デバイス市場の将来的な見通しは明るいです。
当レポートでは、世界の手術用エネルギー器具/電気手術用デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Surgical Energy Instruments Electrosurgical Devices Market By Product (Electrosurgical Generators, Electrosurgical Instruments & Accessories [Electrosurgical Instruments {Monopolar Instruments, Bipolar Instruments}, Electrosurgical Accessories], Argon And Smoke Management Systems, By Application (General Surgery, Orthopedic Surgery, Gynaecology Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery, And Others) By End-User (Hospitals, Ambulatory Surgical Centres, And Others), by geography, is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of chronic disorders, rising surgical procedures across the globe, along with increasing product approvals and launches worldwide.
The Global Surgical Energy Instruments Electrosurgical Devices was valued at USD 8,520.99 million in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 12,401.80 million by 2030. The demand for surgical energy instruments and electrosurgical devices is witnessing growth due to the growing prevalence of chronic disorders such as cardiovascular disorders, neurological disorders, gynecological disorders, and others, the rising number of surgical procedures, the escalating burden of geriatric patients, and technological advancements in product development and design improvement.
Surgical Energy Instruments Electrosurgical Devices Market Dynamics:
The surgical energy instruments electrosurgical devices market is witnessing an increase in market revenue owing to the rising prevalence of various chronic diseases such as heart failure and stroke due to various factors such as genetics, age, obesity, and unhealthy lifestyle. According to the World Health Organization (WHO) (2023), in 2019, cardiovascular disease (CVDs) was one of the leading causes of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Most cardiovascular disorders are treated by some surgery.
Moreover, the rising burden of geriatric patients may increase the prevalence of chronic disorders as age is one of the risk factors for most chronic ailments. For instance, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). Thus, the increasing number of geriatric patients globally may increase the demand for electrosurgical devices during the forecast period.
Another key factor responsible for the growth of the surgical energy instruments electrosurgical devices market is the rising number of surgical procedures across the globe. For example, as per the Lifespan Health System organization (2023), about 5,00,000 open heart surgeries were performed every year in the United States. In addition, as per the Plastic Surgery and Statistics Report (2023), there were approximately 15.6 million cosmetic procedures were performed in the US in the year 2020. The source further stated that there were approximately 13.2 million cosmetic minimally-invasive procedures that were performed in the United States in the year 2020.
Therefore, the rising prevalence of various chronic diseases along with the growing number of surgeries such as open heart surgeries and cosmetic surgeries are expected to contribute to the growing demand for surgical energy instruments, which in turn are expected to aid in increasing the demand for surgical energy instruments electrosurgical devices eventually taking the global surgical energy instruments electrosurgical devices market forward during the forecast period.
However, stringent regulatory guidelines associated with the approval of the surgical energy instruments, and the scarcity of skilled labor force in the healthcare market will also restrain the growth of the surgical energy instruments electrosurgical devices market.
In addition to the previously mentioned factors, the surgical energy instruments electrosurgical devices market witnessed a period of temporary setback due to the imposing of lockdown restrictions as necessary measures to contain COVID-19 and to stop the spread of viral infection. The COVID-19 pandemic lead to severe effects throughout the globe, in every country and their healthcare system, with major impacts not only on the patients infected with COVID-19 but on others as well. The situation had led to the cancellation of several surgeries to manage and reserve the resources, and several hospitals were facing a shortage of professionals that were responsible to assist these surgeries. For instance, as per the British Journal of Surgery Report (2023), in May 2020, around 48,728 surgical procedures per week were canceled in India, which is estimated for around 585,000 surgical procedures for 12 weeks. However, owing to the introduction of vaccines and rising focus by governments on strategized plans for further outbreaks, the demand for surgical energy instruments electrosurgical devices is expected to grow thereby presenting a positive future outlook for the surgical energy instruments electrosurgical devices market in the forecast period.
Surgical Energy Instruments Electrosurgical Devices Market Segment Analysis:
Surgical energy instruments electrosurgical devices market by Product (Electrosurgical Generators, Electrosurgical instruments & accessories [Electrosurgical instruments {Monopolar instruments (Electrosurgical pencils, Electrosurgical electrodes, suction coagulators, and others), Bipolar Instruments (Advanced Vessel Sealing Instruments, Bipolar Forceps)} Electrosurgical accessories], Argon and Smoke Management Systems), Application (General Surgery, Orthopedic Surgery, Gynaecology Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery, and others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product segment of the surgical energy instruments electrosurgical devices market, the electrosurgical instruments and accessories category is expected to dominate the market and is estimated to grow at a CAGR of 7.28% during the forecast period from 2024-2030 to reach USD 7,015.66 million by 2030. This is owing to the increased use of electrosurgical instruments and accessories that include monopolar and bipolar instruments such as electrosurgical pencils, electrosurgical electrodes, advanced vessel sealing instruments, bipolar forceps, and others. Monopolar and bipolar electrodes are increasingly being used in the market, associated with the rising number of various surgical procedures such as cosmetic surgeries. For instance, according to the International Society of Aesthetic Plastic Surgery (2019), approximately 11,363,569 surgical procedures of plastic surgeries were performed in the year 2019 globally. The increasing number of plastic surgeries is due to electrocautery procedure which is a painless procedure, a kind of electrosurgery that is applied in superficial situations faced by dermatologists, ophthalmologists, plastic surgeons, urologists, and other related specialties. Electrocautery devices are attached to electrosurgical electrodes which are used to achieve hemostasis or varying degrees of tissue destruction during plastic surgeries. Therefore, the rising number of cosmetic surgeries will increase the number of electrocautery surgery, ultimately increasing the demand for electrosurgical electrodes, thereby increasing the overall market growth of electrosurgical instruments and accessories during the forecast period.
North America is expected to dominate the overall Surgical Energy Instruments Electrosurgical Devices Market:
Among all the regions, North America is expected to dominate the market in the year 2023 and is estimated to grow at a CAGR of 6.51% during the forecast period from 2024-2030 to reach USD 5,363.75 by 2030. This domination can be primarily attributed to the increasing prevalence of chronic disorders, rising number of cosmetic surgeries, increasing research and developmental activities in the region, and others.
The North America surgical energy instruments electrosurgical devices market is witnessing an upward trend due to the increasing prevalence of chronic disorders, an upsurge in the number of cosmetic surgeries, cardiovascular surgeries, and cesarean operations, along with increased product launches and approvals in the region. As per the data published by the Centers for Disease Control and Prevention (CDC) (2023), one person dies every 36 seconds in the United States from cardiovascular disease. According to the same source, it was estimated that in the year 2023 about 659,000 people in the United States died from heart disease, accounting for one in every four deaths. Most cardiovascular disorders treated with surgical procedures involve the application of electrosurgical devices, leading to increased demand for surgical energy instruments electrosurgical devices market in the region.
Also, as per reports from the Canadian Institute of Health Information (2023), 2.7 million hospitalizations occurred in Canada due to cesarean operations, and cardiovascular operations, among others during the year 2019-2020.
Moreover, product development activities in the North America region are also expected to bolster the demand for surgical energy devices and electrosurgical devices during the forecast period. For instance, in October 2019, Apyx Medical Corporation, an advanced energy technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market and sell the Apyx Plasma/RF Handpiece. The Apyx Plasma/RF Handpiece is an electrosurgical device used in conjunction with compatible generators for cutting, coagulation, and ablation of soft tissue. Hence, the increasing patient pool associated with the requirement of surgical procedures for treatment in the region may result in the growing demand for electro surgery, which in turn will boost the demand for surgical energy instruments electrosurgery devices.
Therefore, all the factors mentioned above would collectively contribute to the growth of the North America surgical energy instruments electrosurgery devices market during the given forecast period.
Surgical Energy Instruments Electrosurgical Devices Market Key Players:
Some of the key players operating in the surgical energy instruments electrosurgery devices market include Medtronic, Olympus, CONMED Corporation, Symmetry Surgical Inc., Applied Medical Resources Corporation, ERBE GmbH, Kirwan Surgical Products, LLC, CIMPMAX, Johnson & Johnson, Boston Scientific Corporation, Bissinger Medizintechnik, Surgical Holdings, Parkell Inc., Utah Medical Products Inc., Novuson, Apyx Medical Corporation, B. Braun Melsungen AG, Hangzhou AGS Medtech Co., Ltd, KLS Martin Group, Smith & Nephew, and others.
Recent Developmental Activities in Surgical Energy Instruments Electrosurgical Devices Market:
In April 2022, Italy-based medical device company I-VASC announced the launch of the VELEX device that can be used for the treatment of Venous Insufficiency and Empty Vein Ablation and provides more safety during surgeries in comparison to conventional sclerotherapy.
In September 2019, Baylis Medical launched VersaCross® Large Access Solution in Canada, for performing Left Atrial Appendage Closure (LAAC) procedures. VersaCross includes the world's first 3-in-1 radiofrequency (RF) with a seamless shapeable dilator for optimizing tissue dilation.
In April 2019, 4T Medical announced the launch of Zeus, a portable electrosurgical device in the United Kingdom, offering control over frequency and power systems, enabling the treatment to be tailored as per the patient's age and skin type.
Key Takeaways from the Surgical Energy Instruments Electrosurgical Devices Market Report Study
Market size analysis for current surgical energy instruments electrosurgical devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the surgical energy instruments electrosurgical devices market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
Key companies dominating the global surgical energy instruments electrosurgical devices market.
Target Audience who can be benefited from this Surgical Energy Instruments Electrosurgical Devices Market Report Study
Frequently Asked Questions for Surgical Energy Instruments Electrosurgical Devices Market:
Electrosurgical devices are medical devices that with the application of electricity cause thermal destruction of tissues through dehydration, coagulation, or vaporization. These devices use high frequency, alternating electric current to produce heating in biological tissue as a means to cut, coagulate or desiccate the tissue.
The Global Surgical Energy Instruments Electrosurgical Devices was valued at USD 8,520.99 million in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 12,401.80 million by 2030.
The Global Surgical Energy Instruments Electrosurgical Devices market is witnessing growth due to the rising prevalence of chronic disorders such as cardiovascular disorders, neurological disorders, gynecological disorders, and others, the rising number of surgical procedures, and escalating burden of geriatric patients.
Some of the key market players operating in the Surgical Energy Instruments Electrosurgical Devices market include Medtronic, Olympus, CONMED Corporation, Symmetry Surgical Inc., Applied Medical Resources Corporation, ERBE GmbH, Kirwan Surgical Products, LLC, CIMPMAX, Johnson & Johnson, Boston Scientific Corporation, Bissinger Medizintechnik, Surgical Holdings, Parkell Inc., Utah Medical Products Inc., Novuson, Apyx Medical Corporation, B. Braun Melsungen AG, Hangzhou AGS Medtech Co., Ltd, KLS Martin Group, Smith & Nephew, and others.
Among all the regions, North America is expected to account for a significant market share in the Surgical Energy Instruments Electrosurgical Devices market. North America is predicted to account for the dominant revenue share because of the increasing prevalence of chronic disorders, upsurge in the number of cosmetic surgeries, cardiovascular surgeries, and cesarean operations, along with increased product launches and approvals in the region.